UDK 61 Медицина. Охрана здоровья
Chronic myeloproliferative diseases are an urgent problem of modern hematology. Despite the fact that these are relatively rare pathologies of the blood system, patients with myeloproliferative diseases are regularly encountered in the practice of a hematologist. The recent increased interest in this group of diseases is due to the increased frequency of their diagnosis in patients of different ages. A clinical observation of a middle-aged patient, diagnostic difficulties and therapy selection is presented.
myeloproliferative disease, nonspecific symptoms, hydroxycarbamide
1. Kutti J., Ridell B. Epidemiology of the myeloproliferative disorders: essential thrombocythaemia, polycythaemiavera and idiopathic myelofibrosis. // Pathol. Biol., 2001, v.4, p.164-164;
2. Johansson P., Kutti J., Andreasson B., Safai-Kutti S., Vilen L., Wedel H., Ridell B. Trends in the incidence of chronic Philadelphia chromosome negative (Ph-) myeloproliferative disorders in the city of Goteborg, Sweden, during 1983-99. // Journal of Internal Medicine, 2004, v.256,p.161-165;
3. Bangerter M., Guthner S., Beneke H. et al. Pregnancy in essential thrombo-cythaemia: treatment and outcome of 17 pregnancies. // Eur. J. Haematol., 2000,v. 65, № 3, p. 165-169;
4. Hasselbalch H.C. Idiopathic myelofibrosis: a review. // Eur. J. Hematol., 1990,v. 45, N 2, p. 65-72;
5. Heis-Vahidi-Fard N., Forberg E., Eichinger S. et al. Ineffectiveness of interferon-gamma in the treatment of idiopathic myelofibrosis: a pilot study. // Ann. Hematol, 2001, v. 80,N 2, p.79-82;
6. Zlokachestvennye novoobrazovaniya v Rossii v 1998 godu (zabolevaemost' i smertnost'). Pod red. V.I. Chissova, V.V. Starinskogo, M.: MNIOI im. P.A. Gercena, 1999, 288 s;
7. Bain B.J. The relationship between the myelodysplastic syndromes and the myeloproliferative disorders. // Leuk. Lymphoma, 1999, v. 34, № 5-6, p. 443-449;
8. Kutti J., Ridell B. Epidemiology of the myeloproliferative disorders: essential thrombocythaemia, polycythaemiavera and idiopathic myelofibrosis. // Pathol. Biol. (Paris), 2001, v. 49, N 2, p. 164-166;
9. Klinicheskaya onkogematologiya, red. Volkovoy M.A. M.; 2001, c.263-300;
10. Shiffman F. Dzh. Patofiziologiya krovi: Per. s angl., M.,SPb.: "Izdatel'stvo BINOM", "Nevskiy dialekt". 2000, 448 s.;
11. AdamkovM., Plank L., Szepe P. Occurrence of myelofibrosis in individual types of chronic myeloproliferative diseases. // Bratisl. Lek.Listy, 1998, v. 99, N. 5, p. 240-244;
12. Murphy S. Diagnostic criteria and prognosis in polycythemia vera and essential thrombocythemia. // Semin. Hematol., 1999., v.36, N.1, Suppl. 2, p.9-13;
13. Tefferi A., Murphy S. Current opinion in essential thrombocythemia: pathogenesis, diagnosis, and management. // Blood. Rev., 2001, v.15, N.3, p.121-131;
14. Bench A.J., Cross N.C., Huntly B.J. et al. Myeloproliferative disorders. // Best. Pract. Res. Clin. Haematol., 2001, v.14, p.531-551;
15. Tefferi A., Vardiman J. W. Classification and diagnosis of myeloproliferative neoplasms: The 2008 World Health Organization criteria and point-of-care diagnostic algorithms. Leukemia 2008, 22: 14- 22;
16. AyalewTefferi, Juergen Thiele, and James W. Vardiman. The 2008 World Health Organization Classification System for Myeloproliferative Neoplasms. // Cancer, 2009, v.115, №9, p. 3842-3847;
17. James W. Vardiman, Julergen Thiele, Daniel A. Arber, Richard D. Brunning, Michael J. Borowitz, Anna Porwit, Nancy Lee Harris, Michelle M. Le Beau, Eva Hellstrom-Lindberg, Ayalew Tefferi, and Clara D. Bloomfield The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. // Blood,2009, v. 114, №5, p.937-951;
18. Sokolova N.A., Savina M.I. // Molodoy uchenyy, 2011, №5, t.2, c. 216-219;
19. MisyurinA.V. Molekulyarnyy patogenez mieloproliferativnyh zabolevaniy. // Klinicheskaya onkogematologiya, 2009, t.2, №3,s.211-219;
20. Gluzman D.F., Sklyarenko L.M., Nadgornaya V.A., Abramenko I.V. Novaya klassifikaciya VOZ opuholey krovetvornoy i limfoidnoy tkani. // Onkologiya, 2001, t.3, №4, s.299-300.
